These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30903739)

  • 1. Dutch multicenter experience using the STENTYS Xposition S self-apposing stent in complex coronary lesions.
    Vlieger S; Simsek C; Balland A; Somi S; Jessurun G; Amoroso G; Kauer F; van Geuns RJ; IJsselmuiden A
    Catheter Cardiovasc Interv; 2019 Dec; 94(7):966-971. PubMed ID: 30903739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-in-man evaluation of the novel balloon delivery system STENTYS Xposition S for the self-apposing coronary artery stent: impact on longitudinal geographic miss during stenting.
    Lu H; IJsselmuiden AJ; Grundeken MJ; Nassif M; de Vries AG; Weevers A; Scholte M; Spaargaren R; Wykrzykowska JJ; Tijssen JG; de Winter RJ; Koch KT
    EuroIntervention; 2016 Mar; 11(12):1341-5. PubMed ID: 25983027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of self-apposing Stentys drug-eluting stent in left main coronary artery PCI: Multicentre LM-STENTYS registry.
    Wańha W; Mielczarek M; Smolka G; Roleder T; Jaguszewski M; Ciećwierz D; Tomasiewicz B; Kubler P; Gorol J; Chmielecki M; Bartuś S; Navarese EP; Kasprzak M; Sukiennik A; Kubica J; Lekston A; Hawranek M; Reczuch K; Gruchała M; Ochała A; Wojakowski W
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):574-582. PubMed ID: 30311397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical performance of a dedicated self-apposing stent for the treatment of left main stem disease. Results of the left Main AngioplasTy wIth a Self-apposing StEnt - the MATISSE study.
    Cortese B; Montefusco A; D'Ascenzo F; La Manna A; Andò G; Bisceglia T; Secco GG; Meyer-Gessner M; Wańha W; Sganzerla P; Napodano M; Di Palma G; Latini RA; Tamburino C; Orrego PS; Baumbach A
    Cardiovasc Revasc Med; 2018; 19(7 Pt B):831-836. PubMed ID: 29661597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of drug eluting self-apposing stent for the treatment of unprotected left main coronary artery disease: 1-year results of the TRUNC study.
    Briguori C; Tamburino C; Jessurun GAJ; Meyer-Geßner M; Reczuch K; Cortese B; Maillard L; Anthonio RL; La Manna A; Morice MC; Bouchez D; Balland A; Huynh VP; Baumbach A
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E142-E148. PubMed ID: 31696618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of the self-aPposing, bAlloon-delivered, siRolimus-eluting stent for the Treatment of the coronary Artery disease: SPARTA, a multicenter experience.
    Montefusco A; De Filippo O; Gili S; Mancone M; Calcagno S; Cirillo P; Esposito G; Poli A; Ferrara E; Smolka G; Wanha W; Palmieri C; Pastormerlo LE; Baumbach A; Sganzerla P; Tamburino C; Bruno F; Secco GG; Nicolino A; Yew KL; di Palma G; Wojakowski W; Sardella G; Rinaldi M; Cortese B; D'Ascenzo F
    Coron Artery Dis; 2020 Jan; 31(1):27-34. PubMed ID: 31658146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes with the STENTYS self-apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction: two-year insights from the APPOSITION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry.
    Lu H; Grundeken MJ; Vos NS; IJsselmuiden AJJ; van Geuns RJ; Wessely R; Dengler T; La Manna A; Silvain J; Montalescot G; Spaargaren R; Tijssen JGP; Amoroso G; de Winter RJ; Koch KT
    EuroIntervention; 2017 Aug; 13(5):e572-e577. PubMed ID: 28191875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study.
    Grundeken MJ; Lu H; Vos N; IJsselmuiden A; van Geuns RJ; Wessely R; Dengler T; La Manna A; Silvain J; Montalescot G; Spaargaren R; Tijssen JGP; de Winter RJ; Wykrzykowska JJ; Amoroso G; Koch KT
    J Invasive Cardiol; 2017 Aug; 29(8):253-258. PubMed ID: 28756418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry.
    Hoppmann P; Kufner S; Cassese S; Wiebe J; Schneider S; Pinieck S; Scheler L; Bernlochner I; Joner M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):822-9. PubMed ID: 26708019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focus on STENTYS
    Pellegrini D; Cortese B
    Future Cardiol; 2019 May; 15(3):145-159. PubMed ID: 31023079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-expanding stent for complex percutaneous coronary interventions: A real life experience.
    Pastormerlo LE; Ciardetti M; Coceani M; Trianni G; Ravani M; Vaghetti M; Rizza A; De Caterina A; Berti S; Palmieri C
    Cardiovasc Revasc Med; 2016; 17(3):186-9. PubMed ID: 26944852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of patients with de novo coronary bifurcation lesions treated with the Tryton Side Branch Stent. The SAFE-TRY prospective multicenter single arm study.
    Tarantini G; La Vecchia L; Galli M; Favero L; D'Amico G; Buja P; Russo F; Cabianca E; Napodano M; Musumeci G; Franceschini E; Grassi G; Pavei A; Bonmassari R; Cernetti C; Spedicato L; Caprioglio F; Reimers B; Isabella G
    Int J Cardiol; 2013 Oct; 168(6):5323-8. PubMed ID: 24007969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-in-man (FIM) study of the Stentys bifurcation stent--30 days results.
    Verheye S; Grube E; Ramcharitar S; Schofer JJ; Witzenbichler B; Kovac J; Hauptmann KE; Agostoni P; Wiemer M; Lefèvre T; Serruys PW; van Geuns RJ
    EuroIntervention; 2009 Mar; 4(5):566-71. PubMed ID: 19378675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The STENTYS self-apposing stent technology in coronary artery disease: literature review and future directions.
    Lu H; De Winter RJ; Koch KT
    Expert Rev Med Devices; 2018 Jul; 15(7):479-487. PubMed ID: 29927344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions.
    Verheye S; Ramcharitar S; Grube E; Schofer JJ; Witzenbichler B; Kovac J; Hauptmann KE; Agostoni P; Wiemer M; Lefèvre T; Spaargaren R; Serruys PW; García-García HM; van Geuns RJ
    EuroIntervention; 2011 Sep; 7(5):580-7. PubMed ID: 21930462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials.
    Bouras G; Jhamnani S; Ng VG; Haimi I; Mao V; Deible R; Cao S; Sudhir K; Lansky AJ
    Catheter Cardiovasc Interv; 2017 May; 89(6):984-991. PubMed ID: 27545721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SPIRIT V study: a clinical evaluation of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions.
    Grube E; Chevalier B; Smits P; Džavík V; Patel TM; Mullasari AS; Wöhrle J; Stuteville M; Dorange C; Kaul U;
    JACC Cardiovasc Interv; 2011 Feb; 4(2):168-75. PubMed ID: 21349455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the complexity of bifurcation lesions treated with drug-eluting stents: the DEFINITION study (Definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts).
    Chen SL; Sheiban I; Xu B; Jepson N; Paiboon C; Zhang JJ; Ye F; Sansoto T; Kwan TW; Lee M; Han YL; Lv SZ; Wen SY; Zhang Q; Wang HC; Jiang TM; Wang Y; Chen LL; Tian NL; Cao F; Qiu CG; Zhang YJ; Leon MB
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1266-76. PubMed ID: 25326748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.